• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.95% Nasdaq Down2.40%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    28.18 Down 3.08(9.85%) Jun 29, 4:00PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.1
    Mean Recommendation (last week):2.2
    Change:-0.1

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:30.36
    Median Target:31.50
    High Target:45.00
    Low Target:14.00
    No. of Brokers:14

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    May 21, 2015BofA/MerrillDowngradeBuyNeutral
    May 20, 2015Canaccord GenuityUpgradeHoldBuy
    May 20, 2015Sun Trust Rbsn HumphreyUpgradeNeutralBuy
    May 6, 2015Robert W. BairdUpgradeNeutralOutperform
    Jan 23, 2015RBC Capital MktsInitiated Sector Perform
    Nov 26, 2014WBB SecuritiesUpgradeBuyStrong Buy
    Oct 28, 2014Robert W. BairdDowngradeOutperformNeutral
    Aug 1, 2014OppenheimerInitiated Outperform
    Jul 29, 2014WBB SecuritiesUpgradeSpeculative BuyBuy
    Jan 21, 2014NeedhamUpgradeHoldBuy

    More Upgrades & Downgrades for SRPT

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy5544
    Buy4333
    Hold8111212
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.